Navigation Links
Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth
Date:4/20/2009

sented an update on its cell proliferation technology at the AACR Conference.

Progen's lead cell proliferation product, PG11047, targets hyper-proliferating cells specifically to inhibit tumor growth, and is currently undergoing two phase 1 clinical trials.

The pre-clinical research presented at the Conference showed the product provides a significant additive anti-cancer effect when combined with Cisplatin and Avastin when compared with either drug alone in lung cancer and prostate cancer models respectively.

Progen is currently progressing PG11047 through early clinical development in parallel to additional translational studies to determine the most promising indications.

Mr Homburg said to date, 44 patients had been treated in the monotherapy PG11047 Phase 1 trial, and over 130 patients in combination studies with approved anti-cancer therapies. The dosing regime in the monotherapy trial has been escalated far beyond Progen's original expectations.

"While we expect to find the maximum dose soon, we already have supporting data that the drug will have a large therapeutic window when given as a monotherapy," he said.

Mr Homburg said the latest findings in Progen's epigenetics and cell proliferation technologies represented another important milestone in the development of its anti-cancer portfolio.

"These latest findings prove we have the technology, the expertise and the resources to progress our strong product pipeline," he said.

"We have a fantastic team of collaborators, who have played a significant role in these achievements.

"We are very pleased to have had the opportunity to present these findings on the world stage, among leaders of the international scientific community."

About Progen

Progen Pharmaceuticals Limited is a biotechnology company committed to the discovery, developme
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
2. ProGenTech Limited Appoints Executive Management Team
3. ProGenTech Completes $21 Million Series C Financing
4. Radioactive progenies of thoron can be measured accurately, thanks to the PTB
5. Neural progenitor cells as reservoirs for HIV in the brain
6. Progen Investor Teleconference Dial In Details
7. Elusive pancreatic progenitor cells found in mice
8. Imaging neural progenitor cells in the living human brain
9. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
10. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... ... magazine. What are the STASH awards? The Significant Technological Achievements in Secretive ... cannabis-cultivation community as well as tried-and-true products that have stood the test of ...
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
(Date:7/31/2015)... (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will emanate ... Football League’s biggest day each year is the Super Bowl. In the two weeks that ... place from the host venue. The 2016 Super Bowl game will mark the 50th time ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New ... It was also the first provider of Exilis non-surgical fat reduction in New ... procedures it has attracted a large International clientele. Many patients travel to New ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... run by GoodThreads. The store can be accessed by visiting http://www.curemeso.org/store . ... which are customizable. The best part: whenever a product is purchased, the Meso ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3
... 50 Percent of Members Say They Don,t Fully Understand the Details ... of Their ... plan,performance varies widely among some insurers across the U.S., yet,contacting plan ... more consistent and positive satisfaction ratings,more renewal business and additional sales ...
... Many people struggle with,compulsive eating and other eating ... too often, they don,t know where to start. Overeaters,Anonymous ... more about its,Twelve-Step path to recovery., Through a ... OA,s program can now download information and personal,compelling stories ...
... the nation,s,leading supplier of replacement medical repair parts ... Health to become their primary,supplier of medical replacement ... organizations and will provide significant,synergies to both organizations., ... health systems and we are,justifiably proud to count ...
... very aggressive disorder. A report published on March 14, ... a case. A 41-year-old man presented with a 6-month ... polypoid tumor of the lower rectum was found at ... Dissemination studies did not show any metastases. He underwent ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, California, ... is a vertically integrated specialty,pharmaceutical company. In ... the Company engages in the research,development, manufacturing, ... cosmetic products., AMDL today announced that ...
... More than 6.1 million,Americans are covered by Health ... since last year, a new census released today,by ... authorized,starting in January 2004. Since then, AHIP has ... the HSA plan market., (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ...
Cached Medicine News:Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 2Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 3Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 4Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 5Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 6Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 7Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 8Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 9Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 10Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 11Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 12Health News:J.D. Power and Associates Reports: Satisfaction with Health Plans Varies Dramatically From Region To Region, Largely Due to Poor Communication From Insurance Providers 13Health News:PartsSource & Adventist Health Sign Agreement for Parts Procurement 2Health News:AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line 2Health News:More Than Six Million Enrolled in Health Savings Account Plans 2
(Date:7/31/2015)... More than 1,500 substance abuse prevention and treatment specialists ... Indianapolis Aug. 2-6 for Community Anti-Drug Coalitions ... The week-long training, held at the JW Marriott, will ... biggest public health challenges – youth drug use. ... intensive training opportunity, offering more than 70 half-day and ...
(Date:7/31/2015)... -- Boston Children,s Hospital physicians report the first cases ... anatomy before undergoing high-risk brain procedures. The four ... brain,s blood vessels) that posed special treatment challenges. ... Journal of Neurosurgery: Pediatrics , the physicians describe ... to create custom, high-fidelity models of the children,s ...
(Date:7/31/2015)... 31, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... previously announced underwritten public offering of 7,666,667 shares ... price of $11.25 per share. The shares of ... issued upon the exercise in full by the ...
Breaking Medicine Technology:Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 23D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4
For use with catalog #0454....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Antigenic Free Protein S, ELISA Method...
Colorimetric Assay of Protein C Activity by STA© Analyzers. Highly purified extract of Agkistrodon c. contortrix venom for specific activation of protein C, with an activator selected specially ...
Medicine Products: